BPC 157 10mg

Quickstart Highlights

Reference-derived details for BPC 157 10mg.

Typical daily dose ranges from 300–500 mcg
Often administered 1–2 times per day for 4–8 weeks
Higher dosing protocols (500–750 mcg, 2–3x daily) are considered more “advanced”
Reconstitute to achieve a practical injection volume (avoid extremely low syringe units)
Store lyophilized in the freezer; reconstituted in the refrigerator

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Approach (3 mL = ~3,333 mcg/mL)

Week	Daily Dosage (mcg)	Units (per injection)
Weeks 1–4	300 mcg (1× daily)	~9 units
Weeks 5–8	500 mcg (1× daily)	~15 units

For a moderate daily regimen, reconstitute with 3 mL of bacteriostatic water (total 10 mg). That yields ~3,333 mcg per mL. Note that 300 mcg is ~9 units, which is slightly below 10 units. If precision is a concern, consider using smaller insulin syringes.

Reconstitution Steps

Recommended for those referencing higher BPC 157 dosing schedules. Reconstitute with 2 mL to reach ~5,000 mcg/mL. Each injection volume remains within a practical range on a 100-unit insulin syringe.

Advanced / Aggressive Approach (2 mL = ~5,000 mcg/mL)

Week	Daily Dosage (mcg)	Units (per injection)
Weeks 1–4	500 mcg (2× daily)	~10 units
Weeks 5–8	750 mcg (2× daily)	~15 units

Draw 3.0 mL of bacteriostatic water into a sterile syringe.
Inject the water slowly along the vial wall to reduce foam.
Gently swirl—avoid vigorous shaking.
Store the reconstituted solution at 2–8 °C (refrigerator), protected from light.
Draw 2.0 mL of bacteriostatic water into a sterile syringe.
Slowly inject the water to minimize foam.
Gently roll/swirl the vial—avoid vigorous shaking.

Supplies Needed

Ensure you have these on hand for a 4–8 week cycle.

Peptide Vials:• 4 wks ≈ 1–2 vials (depending on daily dose)• 8 wks ≈ 2–3 vials
Insulin Syringes:• 1 per injection day (e.g., 8 wks ≈ 56 for once-daily)
Bacteriostatic Water: 1× 30 ml
Alcohol Swabs: 1 box

Protocol Overview

A concise summary of daily use for tissue repair and healing support.

Goal: Enhance recovery and healing processes
Schedule: Daily subcutaneous or intramuscular injections for 4–8 weeks
Dose Range: Typically 300–500 mcg/day; advanced up to 750 mcg multiple times daily
Reconstitution: Use ~2–3 mL for easy measuring (3,333–5,000 mcg/mL)
Storage: Keep lyophilized vials frozen; refrigerate after reconstitution

Dosing Protocol

Suggested daily injection approach based on common reference doses.

Daily Dose: Start around 300 mcg; gradually adjust as needed
Frequency: 1–2 injections per day (increasing frequency for advanced protocols)
Cycle Length: Typically 4–8 weeks (some may extend up to 12 weeks)
Maximum Dose: Up to ~750 mcg per injection, multiple times daily, per advanced references
Timing: Space injections evenly; consistency is key

Storage Instructions

Proper storage ensures peptide integrity.

Lyophilized: Freeze until mixing (−20°C)
Reconstituted: Refrigerate at 2–8°C
Use within 30 days of reconstitution
Avoid repeated freeze-thaw cycles

Important Notes

Practical tips to enhance safety and efficacy.

Always use sterile insulin syringes & rotate injection sites.
For higher frequency injections, split doses throughout the day.
Observe for adverse reactions; consult a professional if concerns arise.
Track progress through the protocol; consider cycling off after 8 weeks if needed.

How This Works

BPC 157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in the stomach, with potential tissue repair and anti-inflammatory properties.

Injury Recovery Support: May promote tendon and ligament healing
Protective Effects: Reported to aid gastrointestinal lining maintenance
Mechanisms still under study; clinical human data is limited

Potential Benefits & Side Effects

Many users report enhanced healing and reduced inflammation, though results can vary.

Potential accelerated tissue repair and recovery
Possible GI protective effects
Side effects may include injection-site discomfort, headache, or nausea
Long-term human data remains limited; caution and monitoring are advised

Lifestyle Factors

Complementary strategies for maximum benefit.

Maintain a balanced diet with sufficient protein intake
Incorporate regular activity and allow proper rest for tissue repair
Manage stress and ensure adequate sleep

Injection Technique

Simple guidelines for safe daily injections.

Clean vial rubber stopper & injection site with alcohol swabs
Insert needle at a 45–90° angle into subcutaneous tissue
Inject slowly & rotate sites (abdomen, thigh, etc.)

Recommended Source

We recommend Prime Lab Peptides for high-purity BPC-157 (10mg).

Verifies ≥99% purity through independent lab testing
Trusted by researchers seeking reliable results
Follows rigorous manufacturing standards for consistent quality
Shop at Prime Lab Peptides

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

Do not start, stop, combine, or change a protocol based only on website content.
Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

– Dosing reference from a university site

BPC-157 (10mg Vial) Open source
Journal of Pharmacological Sciences — Klicek R et al. BPC-157 promotes colocutaneous fistula healing via NO-system modulation (rat model) View Source Open source
Pharmaceuticals (MDPI) — Józwiak M et al. Multifunctionality and possible medical application of BPC-157: literature and patent review (2025) View Source Open source
Current Pharmaceutical Design (PMC) — Sikiric P et al. BPC-157 stable gastric pentadecapeptide: novel therapy for wound healing and tissue repair View Source Open source
Life Sciences — Seiwerth S et al. BPC-157 and standard angiogenic growth factors: gastrointestinal tract healing and beyond View Source Open source
HSS Journal (PubMed) — Vasireddi N et al. Emerging use of BPC-157 in orthopaedic sports medicine: systematic review (2025) View Source Open source
Journal of Orthopaedic Research — Chang CH et al. BPC-157 promotes tendon-to-bone healing in a rat rotator cuff model View Source Open source
WHO (NCBI Bookshelf) — Guideline on safety-engineered syringes for IM, ID, and SC injections in health care settings (2016) View Source Open source
Johns Hopkins Arthritis Center — How to give a subcutaneous injection (patient education resource) View Source Open source
ClinicalTrials.gov — NCT02637284: PCO-02 Phase I safety and pharmacokinetics trial of oral BPC-157 View Source Open source
CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) View Source Open source
Subcutaneous Drug Injection Review (PMC) — Pharmacologic considerations of the subcutaneous route View Source Open source
World Journal of Gastroenterology (PMC) — Sikiric P et al. Pentadecapeptide BPC-157: from GI tract to whole body healing View Source Open source
Prime Lab Peptides — BPC-157 (10 mg) product page (quality and batch documentation) View Source Open source

Contents